Congress criticises drugs industry for misleading advertising

BMJ 2002; 325 doi: (Published 14 December 2002) Cite this as: BMJ 2002;325:1379
  1. Scott Gottlieb
  1. New York

    Some companies have disseminated misleading advertisements for prescription drugs, even after being cited for violations, a report issued by the US Congress says.

    Congressional investigators, from the independent General Accounting Office, also said that drug advertising seemed to produce a major increase in the use of prescription drugs. The study estimated that at least 8.5 million Americans each year request and receive …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial